TY  - RPRT
TI  - Evaluation of nafamostat mesylate safety and inhibition of SARS-CoV-2 replication using a 3-dimensional human airway epithelia model
AU  - Kirkpatrick, L.
AU  - Millard, J.
PY  - 2020
DO  - 10.1101/2020.09.16.300483
UR  - https://www.biorxiv.org/content/10.1101/2020.09.16.300483v1
ID  - 10.1101/2020.09.16.300483
ER  -